Trial Profile
The Effect of Single Dose Carbamazepine on the Pharmacokinetics of Single Dose Nevirapine (Viramune, NVP) and Development of NVP Resistance, PMTCT Program of Moshi, Tanzania (VITA1).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs Carbamazepine (Primary) ; Nevirapine (Primary)
- Indications HIV infections
- Focus Pharmacodynamics; Pharmacokinetics
- Acronyms VITA1
- 06 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jul 2010 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
- 09 Mar 2010 Planned end date changed from 1 Dec 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.